NFE2L2 and Alzheimer disease: Indeed, some AD pathological hallmarks, like neuroinflammation and impaired redox balance, could be therapeutic targets for disease management and recent reports have highlighted the protective role of Nrf2 activation in reducing oxidative stress in both in vitro and in vivo models of neurodegenerative diseases such as AD [4,5,6].